NEUROMUSCULAR DISEASE LISA F. WOLFE, MD A SSOCIATE P ROFESSOR IN M - - PDF document

neuromuscular disease
SMART_READER_LITE
LIVE PREVIEW

NEUROMUSCULAR DISEASE LISA F. WOLFE, MD A SSOCIATE P ROFESSOR IN M - - PDF document

NEUROMUSCULAR DISEASE LISA F. WOLFE, MD A SSOCIATE P ROFESSOR IN M EDICINE -P ULMONARY AND N EUROLOGY N ORTHWESTERN U NIVERSITY F EINBERG S CHOOL OF M EDICINE C HICAGO , IL Dr. Lisa Wolfe is currently an Associate Professor in Medicine-Pulmonary


slide-1
SLIDE 1

NEUROMUSCULAR DISEASE

LISA F. WOLFE, MD

ASSOCIATE PROFESSOR IN MEDICINE-PULMONARY AND NEUROLOGY NORTHWESTERN UNIVERSITY FEINBERG SCHOOL OF MEDICINE CHICAGO, IL

  • Dr. Lisa Wolfe is currently an Associate Professor in Medicine-Pulmonary and Neurology in the

Northwestern University Feinberg School of Medicine. She is a member of the Neurology Faculty in both Sleep and Neuromuscular Medicine. She also works as the Director of Respiratory Care at the Rehabilitation Institute of Chicago, and is a pulmonary consultant to the Les Turner ALS foundation, the Sleep Medicine program of the Lurie Children’s Hospital, and the Muscular Dystrophy Association of Chicago.

  • Dr. Wolfe obtained her Medical Degree from The Ohio State University, and trained in Internal

Medicine at Northwestern University and then stayed on to complete fellowship training in Pulmonary, Critical Care, and Sleep Medicine. She has remained at Northwestern as faculty and developed a special interest in home based ventilation focusing particularly on the needs

  • f those with neuromuscular disorders. Her current research focus on new trends in home

ventilation including advanced modes such as servo-ventilation and volume assured pressure support as well as the use of alternative devices such as diaphragmatic pacing.

OBJECTIVES:

Participants should be better able to:

  • 1. Consider the options available for advanced speech and communications for those patients

with respiratory impairment in the setting of neuromuscular disease.

  • 2. Establish treatment options utilizing appropriate new modes of non invasive ventilation for

those patients with respiratory impairment in the setting of neuromuscular disease.

  • 3. Develop broad range of inputs to best evaluate the need for mechanical ventilation with

mask for those patients with respiratory impairment in the setting of neuromuscular disease.

  • 4. Utilize non invasive ventilation download applications to encourage/ support self care for

those patients with respiratory impairment in the setting of neuromuscular disease

  • 5. Recognize the need for multiple modality airway clearance plans for patients with respiratory

impairment in the setting of neuromuscular disease.

SATURDAY, MARCH 5, 2016 8:30 AM

slide-2
SLIDE 2

3/8/2016 1

Neuromuscular Disease

Lisa F. Wolfe MD Associate Professor of Medicine Northwestern University Feinberg School of Medicine Chicago , Illinois

NAMDRC 2016: The Role of Technology in Pulmonary, Critical Care and Sleep Medicine

  • Dr. Wolfe has received

research grants from ResMed, Synapse Biomedical, Hill Rom, and Respironics, but these do not create a conflict related to the following presentation.

slide-3
SLIDE 3

3/8/2016 2

COI

  • No conflicts related to the topic of this talk
  • No of label uses will be discussed in this talk
  • Conflicts with research studies and consulting

including:

– ResMed – Philips Respironics – Synapse Biomedical – Hill- Rom

Neuromuscular Disease: The Role of Technology

Technology for the NMD patient

  • Airway clearance technologies

– New cough assist technologies – New vibration based technologies

  • Communication technologies

– Leak speech – Voice banking – Gaze Device

  • New/ Old NIV device technologies

– Biphasic cuirass ventilation (BCV)

  • New NIV Devices

– ST devices – VAPS – ASV

  • Device monitoring technologies

The case for full mechanical ventilation with non-invasive interface

  • Battery

– Safety – Portability

  • Sip Ventilation

– CO2 – Mortality

  • Breath stacking

– LVR – Cough – Swallow – Communication

  • 24 hour NIV
  • Cons
slide-4
SLIDE 4

3/8/2016 3

Goals of Respiratory Care in Neuromuscular Disorders

Areas of weakness/ challenge

  • Glottic weakness
  • Swallow impairment
  • Diaphragmatic

– Weakness – Control of ventilation

  • Accessory muscle drop out

– Inspiratory muscles – Expiratory muscles

  • Core muscle weakness
  • Musculoskeletal

– Scoliosis – Seating/ positioning – Chest wall

Weakness related respiratory complications

  • Secretion clearance

– Nasal – Chest – Oral

  • Atelectasis

– Lung volume recruitment – Micro aspiration

  • Communication failure
  • Hypoventilation

Question 1

  • For patients with neuromuscular disorders an

airway clearance plan is helpful. All of the above are important outcomes of regular airway clearance but which is the most important:

  • 1. Improve voice amplification
  • 2. Reduction in work of breathing
  • 3. Mitigate risk of pneumonia
  • 4. Palliate fatigue with eating
slide-5
SLIDE 5

3/8/2016 4

QUESTION 1 For patients with neuromuscular disorders an airway clearance plan is helpful. All of the above are important outcomes of regular airway clearance but which is the most important:

  • 1. Improve voice amplification
  • 2. Reduction in work of

breathing

  • 3. Mitigate risk of pneumonia
  • 4. Palliate fatigue with eating

1. 2. 3. 4.

3% 0% 55% 42%

Airway Clearance

Device Goals

  • Vibration
  • Secretion Consistency:

– Drying vs Waterlike

  • Lung Volume Recruitment
  • Expiratory Support

Device Options

  • Vibration

– Airway Vibration – at the lips – Chest wall Vibration

  • Drying vs Wetting

– Nebulization solution – Humidity – Saliva control

  • Lung Volume Recruitment

– Ambu bag breath stacking – Mechanical “cough” assist – Breath stacking on vent

slide-6
SLIDE 6

3/8/2016 5

Airway Clearance: Vibration

Airway Vibration

  • Pulm Rehab programs have

used devices where the vibrations require significant patient effort

– Concerns in the setting of NMD

  • Insufficient flow
  • Weak “embouchure”

– Devices

  • PEP:

– Flutter,™ Acapella™ AerobikA™ and Cornet™

  • PEP + Acoustic:

– Vibralung™

Chest Wall Vibrations

  • High Frequency Chestwall

Oscillation ( HFCWO) has most commonly been used in the setting

  • f bronchiectasis

– Concerns in the setting of NMD

  • Hypersecreation sputum is not an

issue?

– It can be an issue with: » Siallorhea » Swallow issues with micro aspiration

– Advantages for those with:

  • Cognitive impairment
  • Bulbar dysfunction

– Devices

  • Therapy Vest™
  • AffloVest

Airway Clearance: Vibration

Airway Vibration

  • Pulm Rehab programs have

used devices where the vibrations require significant patient effort

– Concerns in the setting of NMD

  • Insufficient flow
  • Weak “embouchure”

– Devices

  • PEP:

– Flutter,™ Acapella™ AerobikA™ and Cornet™

  • PEP + Acoustic:

– Vibralung™

Electro-Mechanical-Acoustical Airway Clearance: Promotes muckinesis by vibrating the column of gas in the airways with sounds at different

  • frequencies. It is unclear if this

technology will have a role in NMD but there is a promise which other devices in the category don’t have. Patient generated flow is not needed.

McPeck M. Respir Ther 2014; 9(Oct-Nov): 45-47.

slide-7
SLIDE 7

3/8/2016 6

$0.00 $1,000.00 $2,000.00 $3,000.00 $4,000.00 $5,000.00 $6,000.00 $7,000.00 $8,000.00 $9,000.00 $10,000.00

Total Medical Allowed PMPM Total Rx Allowed PMPM Total Medicial & Rx Allowed PMPM Inpatient admissions/1000 Inpatient Allowed PMPM Pulmonary Diagnosis PMPM Pneumonia PMPM

Pre-HFCWO Post-HFCWO * * * * *

Airway Clearance: Vibration

Chest Wall Vibrations

  • Data (N=426; 2007-11) obtained from two large databases of commercial

insurance claims. Patient with NMD codes and started on HFCWO

  • Outcomes included total medical costs per member per month, pharmacy

costs per member per month, inpatient hospitalizations, emergency room visits, and claims for pulmonary diagnoses or pneumonia.

Medical costs per member per month (PMPM)

  • Total cost↓ by $1,111 (12.4%) (p=0.035)
  • Inpatient admission costs ↓by $1,812 (p=0.003)
  • Pneumonia costs ↓ by $326 (p=0.031)

Lechtzin NL; Annals of the American Thoracic Society InPress; 2016

Airway Clearance: Secretion Consistency

Thick

  • Causes

– Dehydration – Over drying – medications

  • Anticholinergics

– Mouth breathing

  • Treatments

– Saline nebs – Humidifiers – Papaya/ Pineapple/ Red grape juice

Waterlike

  • Causes

– Medications

  • Mestinon

– Immobile tongue

  • Treatments

WET DRY

Dry palate and simultaneous drooling due to a weak tongue

slide-8
SLIDE 8

3/8/2016 7

Airway Clearance: Secretion Consistency

Thick Waterlike

  • Botox

New therapies to reduce saliva

  • Suction
  • Ligation
  • Ablation
  • Radiation
  • Future drug:

Tropicamide Films

Airway Clearance: Secretion Consistency

Thick Waterlike

  • Botox
  • The most effective way
  • f treating sialorhea

Squires, N. Dysphagia (2014) 29:500–508 Lakraj, AA Toxins 2013, 5, 1010- 1031

New therapies to reduce saliva

  • Suction
  • No Bite V
  • Deep

suctioning

  • ptions
  • Good for

Oral Care

  • Ligation
  • Complications:

– Airway obstruction – Respiratory insufficiency – Sialoadenitis – Persistent fistula – floor-of-mouth cyst – Ranulas Greensmith, A. PLASTIC AND RECONSTRUCTIVE SURGERY Vol. 116, No. 5 Oct. 2005

slide-9
SLIDE 9

3/8/2016 8

Airway Clearance: Secretion Consistency

Thick Waterlike New therapies to reduce saliva

  • Ablation

– Alcohol ablation of the submandibular, sublingual, and parotid glands – Requires intubation – Complications include facial nerve injuries – No publications

  • Radiation
  • 50% response treated with

photons

  • 87.5% response treated with

electrons

  • Positive responses were more

common with a high total dose (≥ 16 Gy; 78.6%) than a low total dose (< 16 Gy; 33%; P = 0.07)

Avi AssoulineInt J Radiation Oncol Biol Phys,

  • Vol. 88, No. 3, pp. 589-595, 2014
  • Future drug:

Tropicamide Films

clinicaltrials.gov NCT01844648

placebo

Airway Clearance: Lung Volume Recruitment

Ambu bag with breath stacking

  • Significantly positive effect
  • n:

– FVC for up to 15 min following treatment – PCF during unassisted coughing at 30 min following treatment

  • Improves Speech outcomes

– Vocal volume – Swallow

1) McKim DA; Arch Phys Med Rehabil Vol 93, July 2012 2) STUART CLEARY Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2013; 14: 111–115 3) Cleary S; Using Lung Volume Recruitment Therapy to Improve Swallowing and Airway Protection for Individuals with ALS Amyotrophic Lateral Sclerosis 2010;11(1):58-9.

LVR slows loss of FVC

slide-10
SLIDE 10

3/8/2016 9

Airway Clearance: Lung Volume Recruitment

Mechanical Cough Assist

  • Expired volume increases

(2x).

  • MIP/MEP/PEF increases
  • End-tidal carbon dioxide

pressure decrease significantly

Brigitte Fauroux CHEST 2008; 133:161–168

GOALS: 1) Lung Volume Recruitment 2) Chest wall ROM 3) Clear Nose 4) Clear Chest Secretions

Airway Clearance: Lung Volume Recruitment

Breath Stacking

  • Use of sip ventilation

– Breath stacking – Augments cough – Adds patient control – it can be done unassisted

Bach, JR Am. J. Phys. Med. Rehabil. ● Vol. 81, No. 6

slide-11
SLIDE 11

3/8/2016 10

  • No difference between

the bulbar and the non-bulbar groups.

  • Addition of an

inspiratory technique was better.

  • The in/exsufflator was

not always the best tool.

  • Coughing efforts can

be dramatically improved with different tools, even in patients with very severe bulbar symptoms.

  • Tailor cough

improvement techniques to the individual

Airway Clearance: Lung Volume Recruitment

Abd Thrust Coached Unassisted Cough Abd Thrust Breath Stacking Home NIV NIV 30/5 MIE -40/+40

SENENT , C. Amyotrophic Lateral Sclerosis, 2011; 12: 26–32

Question 2

  • Speech and language pathologists should include

respiratory therapists in “co- treats” for patients

  • n ventilators. The answers below are all

reasonable goals for these seasons, which is most important:

1. Assess swallow performance with the tracheal balloon both inflated and deflated 2. Assess secretion burden prior to trialing a speaking valve 3. Adjust mechanical ventilation settings to allow for appropriate ventilation during leak speech 4. Consider tracheostomy changes of both size and type to better facilitate speech.

slide-12
SLIDE 12

3/8/2016 11

QUESTION 2 Speech and language pathologists should include respiratory therapists in “co- treats” for patients on ventilators. The answers below are all reasonable goals for these seasons, which is most important:

1. Assess swallow performance with the tracheal balloon both inflated and deflated. 2. Assess secretion burden prior to trialing a speaking valve. 3. Adjust mechanical ventilation settings to allow for appropriate ventilation during leak speech. 4. Consider tracheostomy changes of both size and type to better facilitate speech.

1. 2. 3. 4.

11% 14% 46% 29%

Communication: Autonomy

  • Autonomy is a central

value in Western medicine and medical ethics

  • The ability to

communicate = Autonomy

– The ability to direct daily self care – The ability to make health care choices – The ability to lead a life of self-realisation

  • Leak speech
  • Voice banking
  • Gaze Device

Varelius, J. Med Health Care Philos. 2006 Dec; 9(3): 377–388.

slide-13
SLIDE 13

3/8/2016 12

Communication: Leak Speech

  • What’s new

– Home vents with passive circuits – Home vents with VERY sensitive leak compensators

  • What does this cause

– More alarms – Compensation can cause severe alkalosis

Hoit, JD Journal of Speech and Hearing Research, Volume 37, 53-63, February 1994 Grossbach, I. Crit Care Nurse 2011, 31:46-60

Communication: Voice Banking

  • Why is this a

discussion for pulmonologists?

– It is part of the discussion of disease progression for all progressive neurologic disorders

  • ALS/ MSA/ etc

– H&N CA

modeltalker.org

slide-14
SLIDE 14

3/8/2016 13

Communication: Gaze Devices

  • Can be used as an

interface between the pt on a vent and:

– Phone – Text – Internet

  • Shopping
  • E-Mail
  • Chat rooms
  • Use in the ICU

http://www.telegraph.co.uk/technology/technology-video/10693581/Eye-tracking-technology-that-makes-life-worth-living.html

Question 3

  • New modes of non – invasive ventilation are

listed below. Which one is these not appropriate for those with neuromuscular disease:

  • 1. Servo- Ventilation
  • 2. Volume Assured Pressure Support
  • 3. VPAP auto / BiPAP auto
  • 4. Pressure Control
slide-15
SLIDE 15

3/8/2016 14

QUESTION 3 New modes of non – invasive ventilation are listed below. Which one is these not appropriate for those with neuromuscular disease:

  • 1. Servo- Ventilation
  • 2. Volume Assured Pressure Support
  • 3. VPAP auto / BiPAP auto
  • 4. Pressure Control

1. 2. 3. 4.

26% 26% 31% 17%

Ventilation: what’s old is new again

  • Biphasic Non-Invasive

Cuirass Ventilator (BCV)

– Negative pressure ventilation – Limited data (esp. in adults) – Can now be used for both NIV and airway clearance – Problems

  • Shell fitting
  • Synchrony
  • Healthcare provider

discomfort

  • Access to device
slide-16
SLIDE 16

3/8/2016 15

Ventilation: what’s old is new again

  • Traditional NIV

devices with a back up rate have a new life:

– Fixed pressure modes:

  • PC
  • ST

– Auto Modes

  • Volume assured

pressure support (VAPS) devices

  • Servo-Ventilation (SV)

devices

  • Remote Monitoring

3 2 1 4

  • Is there a role for the

sleep lab?

  • Ti Extension

– Improved VT – Reduced RR – Reduced WOB – More likely to recruit atelectasis and reduce issues with v/q

  • What does this mean for mode

used?

– Spontaneous- Timed (ST) – to assure Ti time with each breath you would need to use ResMed device. – Pressure – Control (PC) – to assure Ti time with each breath you could use a Respironics device

Ti =1.0 Ti =1.4 Berlowitz, DJ Sleep Med. 2015 Oct;16(10):1301-3.

ALS: The extension of inspiratory time

Ventilation: what’s old is new again

slide-17
SLIDE 17

3/8/2016 16

First Generation VAPS

  • VAPS is an ADD –ON

– Choose mode first – S/ ST or PC – The a Target Tidal Volume is chosen

  • Usually about 8 cc/ kg

IDBwt

  • The only option to achieve

the goal is to increase PS – Slow increase based

  • n averaging VT’s

– Back up rate is fixed – There is an option for “Learned Targets”

  • Is the device “learning” the

best thing?

Second Generation VAPS

  • VAPS is a UNIQUE mode

– AVAPS-AE

  • The mode is not adjustable – it is ST (Philips)
  • Back up rate

– Option for the device to “auto” RR by targeting the RR of the first 15 breaths – Rate can be fixed as well

  • Tidal Volume

– Same targeting as AVAPS – to treat hypoventilation

  • EPAP

– Auto EPAP – Set to target UPPER AIRWAY obstruction

– iVAPS

  • The mode is not adjustable – it is ST ( ResMed)
  • Target - Uses a unique Calculator for Alveolar Ventilation (Va)
  • Back up rate -

– Is a target not a fixed value – is a factor in the Va calculation

Ventilation – Volume Assured Pressure Support (VAPS)

Pitfalls

  • Avoid starting to

low

  • Avoid setting your

ceiling to low

  • Avoid mask leaks

– Invalidates targeting

  • Is there a role for

the sleep lab? Volume Assured Modes with Floating EPAP (AVAPS- AE)

Ventilation – Volume Assured Pressure Support (VAPS)

slide-18
SLIDE 18

3/8/2016 17

Modes of Ventilation – IVAPS

  • Optimize ventilation with an

algorithm that targets Alveolar Ventilation to reduce PCO2

– Adjust for height – Assure stable respiratory rate – Targeting Alveolar Volume

  • How to estimate:

– From the lab system – From the IVAPS device – From eth on line calculator

Ventilation – Volume Assured Pressure Support (VAPS)

IVAPS Calculator

  • Input the height
  • Set the back up rate a smidge

higher then you think and lower then spontaneous

  • Then pick either a vt/kg ideal

body weight OR specific vt goal

  • Then hit calculate to get the

Alveolar volume (Va) to input on eth device settings

C:\Documents and Settings\sleepmd\Local Settings\Temp\Temporary Directory 1 for ResMed%20iVAPS%20Settings%20Calculator_Revise dFinalDraft[1].zip\ResMed iVAPS Settings Calculator_RevisedFinalDraft.mht

slide-19
SLIDE 19

3/8/2016 18

Device Rate

IVAPS

Ventilation – Volume Assured Pressure Support (VAPS)

Home Based NIPPV in NMD: Is VAPS a substitute?

  • Mixed group of NMD patients
  • VAPS seems to have made everything worse???

Sleep quality O2 saturation Max CO2

  • Avg. CO2
  • J. Jaye et al Eur Respir J 2009; 33: 566–573

Ventilation – Volume Assured Pressure Support (PS)

slide-20
SLIDE 20

3/8/2016 19

  • This study suggests that

compliance may be better with VAPS devices.

– In PAP naive pt’s

  • Obstructive and Restrictive

disease

– Followed for one month – VAPS (5:40 vs 4:20) showed better compliance

  • Reduction in variability of

compliance

VAPS P S Kelly, JL Respirology (2014) 19, 596–603

Ventilation – Volume Assured Pressure Support (VAPS)

Ventilation- ASV

  • PS - Augments IPAP when breathing

amplitude is reduced and ensures sufficient respiration when respiratory effort is absent (variable PS)

  • EPAP – Measures upper airway patency and

adjusts as needed (fixed or variable EPAP)

  • Rate - ensures sufficient respiration when

respiratory effort is absent (fixed or variable/auto RR)

Although algorithms employed by different ASV devices vary slightly, the principle of treatment is the same: back-up rate ventilation with adaptive pressure support

Cowie et al. Eur Cardiol Rev 2015.

slide-21
SLIDE 21

3/8/2016 20

Heater Room Controller Sensor

Loop Gain Ventilation- ASV

Ventilation: what’s old is new again IVAPS vs ASV

IVAPS

  • AUGMENTS minute ventilation

so that the patient’s total ventilation is INCREASED to prevent HYPOVENTILATION in the setting of:

– Can’t breath:

  • NMD disorders

– Won’t breath:

  • Genetic

– CCHS

  • CNS disorders

– Bilateral Strokes – Brain stem tumors – Chiari

  • Obesity Hypoventilation (?–

US vs Rest of the World)

ASV

  • STABILIZES ventilation so

that the patient’s total ventilation is DECREASED by buffering apnea to prevent HYPERVENTILATION:

– Loop Gain Instability

  • CHF/ AFib
  • Narcotics
  • Not an issue in NMD???

– NOT ANY MORE » Spinal Cord Injury

slide-22
SLIDE 22

3/8/2016 21

The Case of C- SCI teaches us the following: 1) Absolute CO2 levels can not predict control of breathing or stability of breathing 2) C-SCI therapy remains an inadequately explored situation.

Sankari A; Bascom AT; Chowdhuri S; Badr MS. Journal of Applied Physiology. 116(3):345-53, 2014 Feb 1

Ventilation- ASV Ventilation - Monitoring

  • Goals to monitoring

– Regulation – Physician management – Patient self management

slide-23
SLIDE 23

3/8/2016 22

Ventilation – Monitoring/ Regulation

  • Compliance is not a standard for any other

therapy: – EX: Mean adherence to ICS is 33.8%

  • Compliance continues to improve over time

for patients with NMD – Very different then for pt’s with OSA for whom even NIGHT 1 has been shown to predict long term compliance

Journal of Asthma. 40(1):93-101, 2003 Feb.

  • Sleep. 27(1):134-8, 2004 Feb 1.

This is a retrospective sample of 88 ALS pt’s.

Ventilation – Monitoring/ Self management

  • Goals to monitoring

– In the setting of OSA

  • verall health literacy

level influences:

  • Compliance
  • Cardiac outcomes

– No data in the area

  • f NMD

Li JJ; Sleep. 37(3):571-8, 2014 Mar.

slide-24
SLIDE 24

3/8/2016 23

Ventilation – Monitoring/ MD Management

  • Goals to monitoring

– Physician management

  • Mask fitting
  • Efficacy of therapy

– Are there still question?

  • Are we responsible for data

that is possible to obtain but has not been reviewed?

  • No data on the number of

physicians that

– Look at data – Use data » What parts of the data?

  • Physician time and resources

to evaluate the device and data is not reimbursed.

The software in devices is not:

– Peer reviewed – Paid for by insurance – Regulated as a part of the device

Question 4

  • There is a huge concern in regard to the

escalating use of full mechanical ventilator with mask interface. Neuromuscular patients are most likely to need these devices because off all of the reasons below. Which of these indications has been best accepted by CMS to date:

1. Need for sip ventilation to address dyspnea 2. Provide a mechanism to independently breath stack and cough during the day 3. The presence of persistent elevated PaCO2 4. Support effective vocalization

slide-25
SLIDE 25

3/8/2016 24

QUESTION 4

There is a huge concern in regard to the escalating use of full mechanical ventilator with mask interface. Neuromuscular patients are most likely to need these devices because off all of the reasons below. Which of these indications has been best accepted by CMS to date:

1. Need for sip ventilation to address dyspnea 2. Provide a mechanism to independently breath stack and cough during the day 3. The presence of persistent elevated PaCO2 4. Support effective vocalization

1. 2. 3. 4.

0% 0% 0% 0%

  • New CD on the EO464

reduction in coverage

  • The new standard will be to

use a RAD if the condition is

– " not life-threatening conditions where interruption

  • f respiratory support would

quickly lead to serious harm or

  • death. These policies (for

RADS) describe clinical conditions that require intermittent and relatively short durations of respiratory support."

https://www.cms.gov/ LCDId=33800

6 M 23 M 9 M 35 M

One last question……

The case for mechanical vent. with non-invasive interface

slide-26
SLIDE 26

3/8/2016 25

What are the factors driving this change?

  • Challenges with the current criterion needed to obtain Bi-Level

PAP (BPAP) device.

– In NMD – need is only for either FVC/MIP/PaCO2 or Over night pulse

  • x.

– BUT in other conditions obtaining BPAP may require PSG, NC oxygen trial, etc.

  • Advances in technology that have made the use of mechanical

ventilator with non-invasive interface MUCH easier

– Access to passive circuits, which allow for the use of vented masks. – Smaller more portable devices – Pre – made kits to facilitate the hardware needed for mouth piece ventilation (MPV) – Devices that can be pre-programmed with multiple settings to facilitate day and night use. – Vents that can provide home monitoring and data downloads

  • Pressure to reduce readmission rates in COPD and CHF

Home Ventilation to Reduce Rehospitalization in COPD

Study Plan

  • Retrospective study (N=397)

– Mostly Male and Caucasian – Complex medically ( 1/3 with CAD/HF/DM/Anxiety)

  • Quality improvement programs

– Barnes Healthcare Services (Valodsta, GA) – 2010-2014

  • Program components

– Pharmacist for med teaching – RT for

  • AVAPS- AE /NIV support
  • Home O2
  • Care Co-Ordination

– Visits q30 d X 3 visit then q90 d

  • Stop smoking plans

Study Results

Coughlin S, Liang WE, Parthasarathy S. et al J Clin Sleep Med. 2015 Jan 28.

slide-27
SLIDE 27

3/8/2016 26

The case for mechanical vent. with non-invasive interface

What does a mechanical ventilator have to offer?

  • Battery

– Safety – Portability

  • Sip Ventilation

– CO2 – Mortality

  • Breath stacking

– LVR – Cough – Swallow – Communication

  • 24 hour NIV
  • Cons

– Cost – Humidity – Remote control – Sleep lab are not prepaired

Refs:

1.McKim DA Can Respir J.20(1):e5-9. PMCID: 3628652. 2.Toussaint M, Eur Respir J. 2006;28(3):549-55.

  • 3. Finder JD, Am J Respir Crit Care Med. 2004;170(4):456-65.
  • 4. Toussaint M. Thorax. 2008;63(5):430-4.
  • 5. McKim DA., Can Respir J.18(4):197-215. PMCID: 3205101.
  • 6. Bach JR Chest. 1993;104(6):1702-6.
  • 7. Cleary S. Amyotrophic Lateral Sclerosis 2010;11(1):58-9.
  • 8. Khirani S, Respir Care.59(9):1329-37.
  • 9. Toussaint M. Chest. 2007;131(2):368-75.
  • 10. Bach JR, Am J Phys Med Rehabil. 1998;77(1):8-19.
  • 11. Hill NS. Chest. 1986;90(6):897-905.

The case for mechanical vent. with non-invasive interface

  • Greater than 8 hours per night of

use:

– Need for portability and backup battery. – Further support that could be used with either mask or mouthpiece. – The use of portable ventilators with oral or nasal interfaces can prolong life and delay the need for tracheostomy.

  • Hypcapnea - PaCO2 > 45 despite

the use of adequate nocturnal NIV :

– Need for daytime support mask or mouth piece – The use of daytime support in this group has been shown to stabilize vital capacity, and improve survival.

  • Hypoxemia: If PaO2 is < 60 or

O2 saturation is <92% while awake breathing room air.

– The ATS standards for the care

  • f those with Duchene

muscular dystrophy support this recommendation

  • Daytime dyspnea: A harbinger of

the development of daytime hypercapnea – A resting modified Borg score

  • f >2.5

– Dyspnea with laying flat, performing transfers or engaging in physical therapy

  • Indication for mouthpiece

ventilation, and is recommended in the Canadian Thoracic Society Guidelines.

slide-28
SLIDE 28

3/8/2016 27

The case for mechanical vent. with non-invasive interface

  • Speech:

– If speech is insufficient to allow for safety with telephone use, or productivity with a computer interface

  • Mouthpiece ventilation can be

trialed.

  • Swallow:

– Fatigue with eating or microaspiration

  • mouth piece ventilation facilitated

breath stacking can improve safety with eating and appetite.

  • Very Low Lung Function:

– FVC has reduced to below 30% – This finding predicts the development of daytime hypercapnea, which should be addressed with the initiation of daytime mouthpiece sip ventilation

  • r mask based daytime ventilatory

rest

  • Nocturnal BPAP failure:

– In those who fail to normalize

  • xygenation and/ or ventilation

during sleep with a BPAP at

  • ptimal settings.

– Consider higher pressures to be delivered through a MV or alternative modes utilized such as volume ventilation. – This has been shown to improve survival, and reduces medical complications such as pneumonia.

  • Alarms:

– In young children, or those with very unstable medical conditions, robust alarm systems are needed and this may require the use of a MV.

The case for mechanical vent. with non-invasive interface

  • The problem with

this tug-of-war

  • Whoever pulls to

hard may take the

  • ther guy over the

cliff.

  • Compromise may be

the only way to win.

slide-29
SLIDE 29

3/8/2016 28

Support / Thanks